|
AP16788b-ev
|
Abcepta, Inc.
|
EIF3K [C-term] [RB35950], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP16788b
|
Abcepta, Inc.
|
EIF3K [C-term] [RB35950], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
ATGP3351-250ug
|
NKMax Bio (ATGen)
|
Integrin alpha L beta 2 [23-700 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3351-50ug
|
NKMax Bio (ATGen)
|
Integrin alpha L beta 2 [23-700 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
GTX64552
|
GeneTex International Corporation
|
EIF3K, Rabbit Polyclonal Antibody
|
Human, Rat
|
WB
|
|
|
HY-10161-100mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10161-250mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10161-50mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-104000-10mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-100mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-25mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-5mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-50mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-10mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-25mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-5mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-50mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-108465-10mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
|
HY-108465-25mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
|
HY-108465-5mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
|
HY-108465-50mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
|
HY-112815-10mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-100mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-25mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-5mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
